Skip to main content
. 2020 Mar 14;39(8):1453–1460. doi: 10.1007/s10096-020-03860-5

Table 2.

Analytical performance of cobas® Liat® POCT on frozen samples using the Expanded Gold Standard (EGS) as reference

TP FP FN TN Sensitivity (95% CI) Specificity (95% CI) PPV (95% CI) NPV (95% CI)
cobas® Liat® influenza A 310 8 0 418 100% (99.0–100%) 98.1% (96.3–99.0%) 97.5% (95.1–98.7%) 100% (99.0–100%)
cobas® Liat® influenza B 163 2 0 571 100% (97.7–100%) 99.7% (98.7–99.9%) 98.8% (95.7–99.7%) 100% (99.3–100%)
cobas® Liat® RSV 26 4 0 706 100% (87.1–100%) 99.4% (98.6–99.8%) 86.7% (70.3–94.7%) 100% (99.5–100%)

TP true positives, FP false positives, FN false negatives, TN true negatives, 95% CI 95% confidence intervals, PPV positive predictive value, NPV negative predictive value